SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-045994
Filing Date
2013-08-14
Accepted
2013-08-14 17:56:39
Documents
12
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v351925_10q.htm 10-Q 891644
2 EXHIBIT 31.1 v351925_ex31-1.htm EX-31.1 21367
3 EXHIBIT 31.2 v351925_ex31-2.htm EX-31.2 21325
4 EXHIBIT 32.1 v351925_ex32-1.htm EX-32.1 10666
5 EXHIBIT 32.2 v351925_ex32-2.htm EX-32.2 11132
6 GRAPHIC ft0002img-2.jpg GRAPHIC 102111
  Complete submission text file 0001144204-13-045994.txt   5821728

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT syn-20130630.xml EX-101.INS 669105
8 XBRL TAXONOMY EXTENSION SCHEMA syn-20130630.xsd EX-101.SCH 32407
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syn-20130630_cal.xml EX-101.CAL 25283
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syn-20130630_def.xml EX-101.DEF 145301
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20130630_lab.xml EX-101.LAB 212636
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20130630_pre.xml EX-101.PRE 177383
Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850
Business Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 131039367
SIC: 2834 Pharmaceutical Preparations